Main Article Content

Abstract

Coronavirus disease 2019 is caused by SARS-CoV-2 infection. COVID-19 causes increased levels of proinflammatory cytokines, so CRP and d-dimer levels in COVID-19 patients tend to increase. This study aimed to analyze the correlation between C-Reactive Protein (CRP) levels and D-dimer levels in COVID-19 patients. This research method is analytic observational by using cross-sectional secondary data. The population of this study were all COVID-19 inpatients at Budhi Asih Hospital, East Jakarta, with a sample of 338 patients and were taken by random sampling. The results of this study found that female and male COVID-19 patients had the same risk of being infected with female patients as much as 52,7% and male patients amounting to 47,3%. Most COVID-19 patients occurred at the age of ≥60 years, namely 32,2%. All patients, which is 100% patients had high CRP levels, with a mean of 76,06 mg/L. As for D-dimer levels, 47,9% of patients had normal D-dimer levels and 52,1% had high D-dimer levels with an average of 721,48 ng/mL. The results of the Spearman's correlation test obtained a p value = 0,000, so it can be seen that there is a correlation between C-Reactive Protein (CRP) levels and D-dimer levels in COVID-19 patients with a correlation strength of 0,300 (medium). An increase in CRP levels followed by an increase in D-dimer levels but evaluation of other laboratory examination parameters also needs to be considered.

Keywords

COVID-19 C-Reactive Protein (CRP) D-Dimer

Article Details

How to Cite
Choirunisa, C., Widhyasih, R., & Fajrunni’mah, R. (2023). Correlation of C-Reactive Protein (CRP) Levels with D-Dimer Levels in COVID-19 Patients. Jurnal Ilmu Dan Teknologi Kesehatan, 11(1), 126-139. https://doi.org/10.32668/jitek.v11i1.1317

References

    Athena, A., Laelasari, E. and Puspita, T. (2020) 'Implementation of Disinfection in Preventing Covid-19 Transmission and Potential Risks to Health in Indonesia', Journal of Health Ecology, 19(1), pp. 1–20. doi: 10.22435/jek.v19i1.3146.

    Benziger, CP et al. (2021) 'The Telehealth Ten: A Guide for a Patient-Assisted Virtual Physical Examination', American Journal of Medicine, 134(1), pp. 48–51. doi: 10.1016/j.amjmed.2020.06.015.

    Berhandus, C., Ongkowijaya, JA and Pandelaki, K. (2021) 'Relationship of Vitamin D Levels and C-Reactive Protein Levels with Clinical 2019 Coronavirus Disease Patients', e-CliniC, 9(2), pp. 370–378. doi: 10.35790/ecl.9.2.2021.33043.

    Chang, M.C., Hur, J. and Park, D. (2020) 'Interpreting the COVID-19 Test Results: A Guide for Physiatrists', American Journal of Physical Medicine and Rehabilitation, 99(7), pp. 583–585. doi: 10.1097/PHM.0000000000001471.

    Chen, W. et al. (2020) 'Plasma CRP levels are positively associated with the severity of COVID-19', Annals of Clinical Microbiology and Antimicrobials, 19, pp. 1–7. doi: 10.1186/s12941-020-00362-2.

    COVID-19 Handling Task Force (2021) COVID-19 Distribution Map, committee for handling COVID-19 and National Economic Recovery. Available at: https://covid19.go.id/peta-sebaran-covid19 (Accessed: 7 April 2021).

    Dashraath, P. et al. (2020) 'Coronavirus disease 2019 (COVID-19) pandemic and pregnancy', American Journal of Obstetrics and Gynecology, 222(6), pp. 521–531. doi: 10.1016/j.ajog.2020.03.021.

    DKI Jakarta Health Service (2021) 'Village-Based COVID-19 Statistical Information', https://corona.jakarta.go.id/. Available at: https://corona.jakarta.go.id/id/statistik-covid-19-berbasis-kelurahan (Accessed: 31 December 2021).

    DKI Jakarta Health Service (2022) 'List of Referral Hospitals', https://corona.jakarta.go.id/. Available at: https://corona.jakarta.go.id/id/contact (Accessed: 7 February 2022).

    DKI Jakarta Health Service (2022) 'Monitoring Data', https://corona.jakarta.go.id/. Available at: https://corona.jakarta.go.id/en/data-pemantauan (Accessed: 10 February 2022).

    DKI Jakarta Health Service (2022) 'Old Terminology Data', https://corona.jakarta.go.id/. Available at: https://corona.jakarta.go.id/id/terminologi-lama (Accessed: 12 June 2022).

    DxGen (2020) 'Multi-marker Point-of-care Testing System EPHITOD®616', pp. 1–26.

    EDAN Diagnostics (2020) Product Catalogue, Edan Instruments. Available at: https://www.edan.com/Uploads/20201027035530_187173.pdf (Accessed: 28 December 2021).

    Gonçalves, FAR et al. (2021) 'Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study', Clinics (Sao Paulo, Brazil), 76 (1), p. e3547. doi: 10.6061/clinics/2021/e3547.

    Hao, W. et al. (2021) 'Binding of the SARS-CoV-2 spike protein to glycans', Science Bulletin, 2019. doi: 10.1016/j.scib.2021.01.010.

    Kahar, F. et al. (2020) 'The Epidemiology of COVID-19, Attitudes and Behaviors of the Community During the Covid Pandemic in Indonesia', International Journal of Innovative Science and Research Technology, 5(8), pp. 1681–1687. doi: 10.38124/ijisrt20aug670.

    Kalma, K. (2018) 'Study of C-Reactive Protein (Crp) Levels in Type 2 Diabetes Mellitus Patients', Health Analyst Media Journal, 1(1). doi: 10.32382/mak.v1i1.222.

    Indonesian Ministry of Health (2021) 'Decree of the Minister of Health of the Republic of Indonesia number hk.01.07/menkes/4642/2021 concerning the implementation of examination laboratories', 2019, pp. 1–69.

    Kumar, S. et al. (2019) 'Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2', 2, pp. 23–31.

    Lazuardi, BP (2018) Relationship between the severity of dengue infection and ALT and C-Reactive Protein levels in pediatric patients at Saiful Anwar Hospital, Malang. Brawijaya University.

    Levani, Prastya and Mawaddatunnadila (2021) 'Coronavirus Disease 2019 (COVID-19): Pathogenesis, Clinical Manifestations and Therapeutic Options', Journal of Medicine and Health, 17(1), pp. 44–57. Available at: https://jurnal.umj.ac.id/index.php/JKK/article/view/6340.

    Long, C. et al. (2020) 'Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?', European Journal of Radiology, 126(March), p. 108961. doi: 10.1016/j.ejrad.2020.108961.

    Luo, X. et al. (2020) 'Prognostic Value of C-Reactive Protein in Patients with Coronavirus 2019', Clinical Infectious Diseases, 71(16), pp. 2174–2179. doi: 10.1093/cid/ciaa641.

    Manzoor, D. et al. (2021) 'Improvement in plasma D-dimer levels in severe SARS-CoV-2 infection can be an indicator of fi brinolysis suppression', 0(March).

    Maryati, W. et al. (2022) 'Characteristic Analysis of Inpatients with Covid-19 Cases', Infokes: Scientific Journal of Medical Records and Health Informatics, 12(1), pp. 20–25. doi: 10.47701/infokes.v12i1.1354.

    McFadyen, J.D. et al. (2018) 'Dissociation of C-reactive protein localizes and amplifies inflammation: Evidence for a direct biological role of C-reactive protein and its conformational changes', Frontiers in Immunology, 9(JUN). doi: 10.3389/fimmu.2018.01351.

    Mosquera-Sulbaran, JA et al. (2021) 'C-reactive protein as an effector molecule in Covid-19 pathogenesis', Reviews in Medical Virology, 31(6). doi: 10.1002/rmv.2221.

    Nanda Nur Illah, M. (2021) 'Analysis of the Influence of Comorbidities, Age and Gender on Increasing Death Rates during the Covid-19 Pandemic', Journal of Social Science, 1(10), pp. 1228–1233. doi: 10.36418/sosains.v1i10.232.

    Paez, D. et al. (2020) 'COVID-19 pandemic: guidance for nuclear medicine departments', European Journal of Nuclear Medicine and Molecular Imaging, 47(7), pp. 1615–1619. doi: 10.1007/s00259-020-04825-8.

    Park, WB et al. (2020) 'Virus Isolation from the First Patient with SARS-CoV-2 in Korea', J Korean Med Sci, 7. doi: https://doi.org/10.3346/jkms.2020.35.e84.

    Pathak, A. and Agrawal, A. (2019) 'Evolution of C-reactive protein', Frontiers in Immunology, 10(APR). doi: 10.3389/fimmu.2019.00943.

    Pourbagheri-sigaroodi, A. (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource center is hosted on Elsevier Connect , the company's public news and information', Clinica Chimica Acta 510, (January).

    Riley, R. S. et al. (2016) 'Widely used types and clinical applications of D-dimer assay', Lab Medicine, 47(2), pp. 90–102. doi: 10.1093/labmed/lmw001.

    Romagnoli, S., Peris, A. and Gaudio, AR De (2020) 'SARS-CoV-2 and COVID-19 : from the bench to the bedside', Physiological Reviews.

    Samprathi, M. and Jayashree, M. (2021) 'Biomarkers in COVID-19: An Up-To-Date Review', Frontiers in Pediatrics, 8(December 2019), pp. 1–12. doi: 10.3389/fped.2020.607647.

    Satria, Tutupoho, and Chalidyanto. (2020) 'Analysis of Risk Factors for Death with Covid-19 Comorbid Disease', Silampari Nursing Journal, 4(1), pp. 1689–1699.

    COVID-19 Handling Task Force (2021) COVID-19 Distribution Map, committee for handling COVID-19 and National Economic Recovery. Available at: https://covid19.go.id/peta-sebaran-covid19 (Accessed: 7 April 2021).

    Shah, S. et al. (2020) 'Elevated d -dimer levels are associated with increased risk of mortality in coronavirus disease 2019: A systematic review and meta-analysis', Cardiology in Review, 28(6), pp. 295–302. doi: 10.1097/CRD.0000000000000330.

    Sheikhi, K., Shirzadfar, H. and Sheikhi, M. (2020) 'A Review on Novel Coronavirus (Covid-19): Symptoms, Transmission and Diagnosis Tests Research in Infectious Diseases and Tropical Medicine A Review on Novel Coronavirus (Covid- 19 ): Symptoms , Transmission and Diagnostic Tests', Research in Infectious Diseases and Tropical Medicine, 2(1), pp. 1–8.

    Sheriff, A. et al. (2021) 'C-Reactive Protein Triggers Cell Death in Ischemic Cells', Frontiers in Immunology, 12(February), pp. 1–8. doi: 10.3389/fimmu.2021.630430.

    Shi, C. et al. (2020) 'The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study', Clinical and Translational Science, 13(6), pp. 1087–1095. doi: 10.1111/cts.12880.

    Sproston, NR and Ashworth, JJ (2018) 'Role of C-reactive protein at sites of inflammation and infection', Frontiers in Immunology, 9(APR), pp. 1–11. doi: 10.3389/fimmu.2018.00754.

    Sumantri, S. (2022) Getting to Know Cytokine Storms, Causes of Organ Damage in COVID-19 Patients, www.siloamhospitals.com. Available at: https://www.siloamhospitals.com/information-siloam/article/mengenal-badai-sitokin-besar-kekerasan-organ-pada-patient-covid-19 (Accessed: 19 July 2022).

    Sun, J. et al. (2020) 'COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives', Trends in Molecular Medicine, 26(5), pp. 483–495. doi: 10.1016/j.molmed.2020.02.008.

    Ullah, W. et al. (2020) 'Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19 ABSTRACT', Journal of Community Hospital Internal Medicine Perspectives, 10(5), pp. 402–408. doi: 10.1080/20009666.2020.1798141.

    Valerio, L. et al. (2021) 'Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients', Thrombosis and Haemostasis, 121(1), pp. 98–101. doi: 10.1055/s-0040-1721317.

    Velavan, TP and Meyer, CG (2020) 'The COVID-19 epidemic', Tropical Medicine and International Health, 25(3), pp. 278–280. doi: 10.1111/tmi.13383.

    Vita, G. and Syambani, Z. (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource center is hosted on Elsevier Connect , the company 's public news and information', Med Clin (Barc), (January), pp. 143–151.

    Wati, L. et al. (2021) 'C-Reactive Protein Correlates with D-Dimer Levels', 5(1), pp. 1–9.

    Weitz, JI, Fredenburgh, JC and Eikelboom, JW (2017) 'A Test in Context: D-Dimer', Journal of the American College of Cardiology, 70(19), pp. 2411–2420. doi: 10.1016/j.jacc.2017.09.024.

    WHO (2020) 'Diagnostic tests for SARS-CoV-2', Interim Guidance, pp. 1–19.

    WHO (2022) Coronavirus disease (COVID-19), https://www.who.int/health-topics. Available at: https://www.who.int/health-topics/coronavirus#tab=tab_3 (Accessed: 16 May 2022).

    William et al. (2020) 'Coagulopathy in Coronavirus Disease -2019 (COVID-19): Literature review', Medical Science Digest, 11(3), pp. 749–756. doi: 10.15562/ism.v11i3.766.

    World Health Organization (2021) About us : World Health Organization, WHO. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Accessed: 6 April 2021).

    Yang, C. et al. (2021) 'Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia', International Journal of Cardiology, 326, pp. 230–236. doi: 10.1016/j.ijcard.2020.09.048.

    Yang, Y. et al. (2020) 'SARS-CoV-2: characteristics and current advances in research', Virology Journal, 17(1), pp. 1–17. doi: 10.1186/s12985-020-01369-z.

    Yu, B. et al. (2020) “Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis,” Journal of Thrombosis and Thrombolysis, 50(3), hal. 548–557. doi: 10.1007/s11239-020-02171-y.

    Zadeh, M.T. et al. (2018) 'Diagnostic Value of Hematologic and Inflammatory Profile in Adjunction to Blood Culture in Patients Suspected of Septicemia', International Journal of Pediatrics-Mashhad, 6(1), pp. 6903–6910. doi: 10.22038/ijp.2017.23837.2015.

    Zhang, Z. L. et al. (2020) “Laboratory findings of COVID-19: a systematic review and meta-analysis,” Scandinavian Journal of Clinical and Laboratory Investigation, 80(6), hal. 441–447. doi: 10.1080/00365513.2020.1768587.

    Zhou, F. et al. (2020) “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study,” The Lancet, 395(10229), hal. 1054–1062. doi: 10.1016/S0140-6736(20)30566-3.

    Zhu, J. et al. (2020) “Correlations of ct scan with high-sensitivity c-reactive protein and d-dimer in patients with coronavirus disease 2019,” Pakistan Journal of Medical Sciences, 36(6), hal. 1391–1401. doi: 10.12669/PJMS.36.6.2961.